Creating a defect in tRNA molecules could weaken bacteria’s two-pronged defense and help make faster-acting antibiotics
Antibiotic resistance is a major health threat, with about two million people in the U.S. getting an antibiotic-resistant infection per year, according to the Centers for Disease Control and Prevention (CDC). Gram negative bacteria, including types like E.coli and Salmonella, are often more difficult to kill because of their two-pronged defenses – they have two membranes rather than one, and also have numerous toxin pumps embedded in the membranes to expel any antibiotic that may have made it through. Now Jefferson researchers have uncovered how to target both of these defenses with one hit, which could help make antibiotics more effective.
“We showed that interfering with a transfer RNA (tRNA) molecule, in a way that is unique to bacteria, cripples the bacterial cell’s ability to make membrane proteins required for the drug barrier and efflux activity,” says senior author Ya-Ming Hou, PhD, Professor of Biochemistry at the Sidney Kimmel Medical College at Jefferson (Philadelphia University + Thomas Jefferson University). The work was published in the journal Cell Systems.
tRNA molecules are not a typical antibiotic target. These molecules are part of the protein-building machinery that is essential for the daily function of cells in every living being. However, Dr. Hou’s team examined a kind of chemical “decoration” process in bacterial tRNAs that is absent from human cells. This difference between bacteria and humans makes this process a better drug target, since it’s less likely affect human cells.
tRNAs are decorated with chemical groups that are added on after tRNAs are synthesized in a cell. Dr. Hou’s group examined one such decoration, the addition of a methyl group to one particular location on the spine of several tRNAs. In earlier work, Dr. Hou’s lab showed that when these tRNAs were deficient in this one methylation, they were more likely to create errors in protein building. But not just any protein, the deficient tRNAs were particularly prone to mistakes at building proteins that sit within cell membrane.
This result made Dr. Hou think that perhaps a defect in the tRNA methylation might affect not only the bacteria’s toxin-pump, but a host of other types of proteins that help keep the membrane stable and cohesive.
In this paper, together with first author postdoctoral fellow Isao Masuda and others, Dr. Hou tested whether these defective tRNAs could make bacteria more susceptible to antibiotics, by creating bacteria that are genetically deficient in making the methyl-group decoration.
Through an elegant series of experiments, Dr. Hou’s team showed that these bacteria had membranes that were less cohesive and more permeable than normal. The bacteria with defective tRNAs were less effective at pumping out chemicals relative to the normal bacteria, suggesting that their toxin pumps were affected. Finally, the team showed that when the bacteria with defective tRNAs were exposed to various antibiotics, they died faster and were also less capable of developing drug resistance.
“Speed of killing is important in antibiotics,” says Dr. Hou. “The longer it takes for bacteria to die from antibiotics, the more likely they are to develop resistance.”
While pharmaceutical companies such as AstraZeneca and GSK have discovered compounds that can inhibit the enzyme from making the critical methylation on tRNAs, progress has stalled. The primary reason is that the inhibitors are unable to permeate through the bacterial membrane structure, which resonates with the major challenge confronting the entire field of antibiotic discovery.
Dr. Hou acknowledges the challenge. “First, we need to formulate the inhibitors in such a way as to be able to enter the cell more effectively,” says Dr. Hou. “Then, combining these inhibitors with traditional antibiotics to kill bacteria faster and reduce the likelihood of antibiotic resistance.”
At the moment, there are no drugs that can effectively attack this pathway. Dr. Hou’s lab is currently working on developing better inhibitors.
Learn more: Breaking Open the Gates of Antibiotic Resistance
The Latest on: Antibiotic resistance
[google_news title=”” keyword=”antibiotic resistance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic resistance
- A vaccine to combat antibiotic resistanceon April 27, 2024 at 2:00 pm
A team of researchers at Michigan State University have outlined an approach to combating a prevalent public health issue: the development of treatment-res | Technology ...
- Cats And Dogs Can Spread Antibiotic Resistant Superbugs To Ownerson April 27, 2024 at 10:55 am
Transfer of bacteria between sick pets and their humans may be contributing to antibiotic resistance, according to new research.
- Experts develop way to harness CRISPR technology to deal with antimicrobial resistanceon April 26, 2024 at 3:10 pm
Antimicrobial resistance (AMR) is continuing to increase globally, with rates of AMR in most pathogens increasing and threatening a future in which every day medical procedures may no longer be ...
- Common antibiotic Neosporin may shield against viral respiratory infectionson April 26, 2024 at 9:00 am
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- What to Know About Pivya, the New Antibiotic Treatment for UTIson April 26, 2024 at 4:06 am
The Food and Drug Administration recently approved Pivya (pivmecillinam) to treat uncomplicated UTIs in female adults. Clinical trials show that Pivya is effective and side effects are limited.
- Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistanceon April 25, 2024 at 5:25 pm
Public Health Emergency, a group of international political, public health, and biomedical leaders warns of another menace to human life that could also trigger economic loss. Antimicrobial ...
- A Vaccine to Fight Antibiotic Resistanceon April 25, 2024 at 2:25 pm
MSU, Harvard Medical School team up to expand vaccine science’s role in the fight against MRSA and other infections ...
- Climate change fuels the rise of global antimicrobial resistanceon April 25, 2024 at 10:34 am
Climate change exacerbates antimicrobial resistance by altering environments where microbes thrive, leading to increased disease spread.
- Researchers develop vaccine to fight antibiotic resistanceon April 24, 2024 at 11:37 pm
Driven by the overuse of antimicrobials, pathogens are quickly building up resistances to once-successful treatments. It’s estimated that antimicrobial-resistant infections killed more than 1 million ...
- Antibiotic resistance in babies varies according to mode of birth, prematurity and where they live, says analysison April 24, 2024 at 3:10 pm
A meta-analysis of genetic studies analyzing the microbiota (bacteria in the gut) of 1,275 infants from 10 countries finds that cesarean delivery and antibiotic use are driving the increase of ...
via Bing News